IMRN

20 stories · following the connections

Business

Immuron Granted US Patent for NASH Treatment

By Nasdaq OMXNov 15, 2017, 2:00 PM UTC

Business

Immuron Successfully Completes NASH Phase II Clinical Study Milestone

By Nasdaq OMXNov 9, 2017, 2:01 PM UTC

Business

Travelan Experiences Strong Q1 FY2018 Sales Growth

By Nasdaq OMXNov 8, 2017, 2:02 PM UTC

Business

Immuron Commences US Non-Deal Institutional Investor Roadshow

By Nasdaq OMXAug 15, 2017, 1:15 PM UTC